Why the study?
Does paroxetine exposure during the first trimester increase the risk of major congenital malformations compared to other antidepressants?
Does paroxetine exposure during the first trimester increase the risk of major congenital malformations compared to other antidepressants?
Answers are grounded in this paper and cite their sources.
First-trimester exposure to paroxetine is associated with a more than twofold increased risk of major congenital malformations, particularly cardiovascular defects, compared to other antidepressants.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Michael F. Greene (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: